×
GLH694 Study – Alcon

GLH694 Study – Alcon

Additive Effect of Twice Daily Brinzolamide 1% Brimonidine 0.2% Fixed Dose Combination as an Adjunctive Therapy to a Prostaglandin Analogue.

A study to investigate the combined effect of Simbrinza with other eye medication on glaucoma.

Trial Registry Number: 2015-000736-15

Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

Request an appointment